BIOLIFE4D Appoints Management Advisory Board
28. Januar 2019 08:30 ET
|
BIOLIFE4D Corporation
CHICAGO, Jan. 28, 2019 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has established a...
BIOLIFE4D Successfully Demonstrates Ability to 3D Bioprint Human Cardiac Tissue
25. Juni 2018 08:00 ET
|
BIOLIFE4D Corporation
CHICAGO, June 25, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has successfully...
BIOLIFE4D Modifies its Regulation A+ (Mini-IPO) Offering Due to Popular Demand
23. Juni 2018 08:00 ET
|
BIOLIFE4D Corporation
CHICAGO, June 23, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it will be modifying...
BIOLIFE4D Establishes Operations in Houston as Part of Commercialization Strategy for Life-Saving 3D Bioprinting Technology
29. Mai 2018 08:02 ET
|
BIOLIFE4D Corporation
CHICAGO, May 29, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is now a resident...
BIOLIFE4D Signs Laboratory Service Agreement with Northwestern University
05. Februar 2018 08:01 ET
|
BIOLIFE4D Corporation
CHICAGO, Feb. 05, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has signed a...
BIOLIFE4D Launches Regulation A+ (Mini-IPO) Offering; Plans to Raise $50M
01. Februar 2018 06:00 ET
|
BIOLIFE4D Corporation
CHICAGO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has launched a...
BIOLIFE4D Targets High Growth Healthcare 3D Printing Market as it Readies for Regulation A+ Offering
17. Januar 2018 07:32 ET
|
BIOLIFE4D Corporation
CHICAGO, Jan. 17, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today commented on the high growth...
BIOLIFE4D Names Dr. Ravi Birla as its Chief Science Officer
02. Januar 2018 08:01 ET
|
BIOLIFE4D Corporation
CHICAGO, Jan. 02, 2018 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has named Dr....
BIOLIFE4D Helping Others to Give the Gift of Time this Holiday Season
20. Dezember 2017 09:00 ET
|
BIOLIFE4D Corporation
CHICAGO, Dec. 20, 2017 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it is taking...
BIOLIFE4D Comments on New Guidelines for High Blood Pressure in Adults
05. Dezember 2017 08:01 ET
|
BIOLIFE4D Corporation
CHICAGO, Dec. 05, 2017 (GLOBE NEWSWIRE) -- BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today commented on a new report from...